Epidemiological Assessment of Hepatitis C among People Who Inject Drugs in Puerto Rico
Funded by: Abbvie Pharmaceutical Research and Development
Project dates: February 2022 - February 2023
Principal Investigator: Aponte-Meléndez, Yesenia

This mixed-methods pilot study that aimed to assess:

  1. HCV seroprevalence and prevalence of HCV viremia among people who inject drugs (PWID) in Puerto Rico,
  2. HCV treatment awareness, barriers to treatment utilization, and willingness to access HCV care among PWID, and
  3. Feasibility of using dried blood spots (DBS) in community based-settings.

In addition, this study assessed medical and social service providers’ views of HCV treatment with direct-acting antiviral (DAAs) for PWID.